Facebook
Linkedin
Mail
X
Youtube
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Search
Facebook
Linkedin
Mail
X
Youtube
Cardiovascular News
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Tag: Evolut Pro
Clinical outcomes similar at one-year for leading TAVI platforms in real-world registry, but stroke rates differ
24th November 2023
A comparison of two l...
ADVERTORIAL: Evolut PRO+ provides options in the toughest TAVI cases
2nd February 2022
This advertorial is spons...
Evolut gets CE mark in low-risk patients and new labelling for bicuspid use
22nd June 2020
Medtronic has been aw...
Bicuspid TAVI outcomes as good as those for tricuspid
5th June 2020
Clinical and echocard...
FDA approves Evolut PRO+
23rd September 2019
The US Food and Drug ...
TAVI pacemaker issue is “an engineering problem that will be solved”
28th March 2017
The SURTAVI trial ind...
ACC 2017: FDA approves launch of CoreValve Evolut Pro
22nd March 2017
The FDA has approved ...
